Cargando…
Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: an open label pilot study
Background: Acne is a debilitating disorder that requires proper treatment depending on the clinical manifestations and pathogenetic factors, among which hyper-keratinization, seborrhea and bacterial proliferation. Combining active ingredients targeting the different mediators of acne pathogenesis m...
Autores principales: | Garofalo, Virginia, Cannizzaro, Maria Vittoria, Mazzilli, Sara, Bianchi, Luca, Campione, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526677/ https://www.ncbi.nlm.nih.gov/pubmed/31190944 http://dx.doi.org/10.2147/CCID.S182317 |
Ejemplares similares
-
New developments in acne treatment: role of combination adapalene–benzoylperoxide
por: Kim, Su Youn, et al.
Publicado: (2016) -
The antioxidant and prebiotic properties of lactobionic acid
por: Goderska, Kamila
Publicado: (2019) -
The Utilization of Pseudomonas taetrolens to Produce Lactobionic Acid
por: Goderska, Kamila, et al.
Publicado: (2014) -
Stereoselective biotransformation of racemic mandelic acid using immobilized laccase and (S)-mandelate dehydrogenase
por: Chen, Xing, et al.
Publicado: (2017) -
Evaluation of Microencapsulated Synbiotic Preparations Containing Lactobionic Acid
por: Goderska, Kamila, et al.
Publicado: (2021)